Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 151 clinical trials
RAMBLE - Rivaroxaban vs. Apixaban for Heavy Menstrual Bleeding

A large proportion of women with menstruating potential with newly diagnosed VTE or atrial fibrillation, treated with apixaban will have less menstrual blood loss than patients randomized to rivaroxaban.

anticoagulation therapy
rivaroxaban
apixaban
anticoagulants
  • 210 views
  • 23 Jan, 2021
  • 2 locations
: Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery

To evaluate the pharmacokinetics of thromboprophylactic doses of LMWH enoxaparin in postoperative CABG patients, drug is administered either as a continuous intravenous infusion (CIV) or subcutaneous bolus (SCB) once per 72h. Plasma anti-Xa values are measured 12-14 times during study period and concentration maximums calculated to enable comparison of anti-Xa …

enoxaparin
  • 26 views
  • 03 Mar, 2021
  • 1 location
Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban

The objective of this study is to compare oral rivaroxaban with injectable enoxaparin in orthopaedic trauma patients to determine if orally administered rivaroxaban once daily carries greater compliance and overall satisfaction than enoxaparin self-administered by subcutaneous injection once daily.

thrombosis
deep venous thrombosis of lower extremity
venous thrombosis
thrombosis prophylaxis
deep vein thrombosis
  • 5 views
  • 23 Jan, 2021
  • 1 location
Venous Thromboembolism in Myotonic Dystrophy Type 1

population matched on age and sex. These venous thromboembolic events were frequently severe and lethal. Investigators suspect that this high risk of venous thromboembolism is due to coagulation

monocytes
pulmonary embolism
thromboembolic events
  • 25 views
  • 03 Feb, 2021
  • 2 locations
PET Fibrin Imaging of DVT and PE

This study aims to investigate a novel positron emission tomography(PET)-probe for imaging of fresh intravascular blood clots in pulmonary embolism (PE) and deep venous thrombosis (DVT).

thrombosis
pulmonary embolism
computed tomography angiography
angiography
venous thrombosis
  • 19 views
  • 23 Jan, 2021
Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis

This study will assess the safety and effectiveness of a drug called apixaban for the treatment of upper extremity deep vein thrombosis (UEDVT) and clinically important bleeding. Subjects will receive apixaban 10 mg by mouth twice a day for 7 days, followed by 5 mg by mouth twice a day …

thrombosis
deep venous thrombosis of lower extremity
drug test
venous thrombosis
heparin
  • 212 views
  • 23 Jan, 2021
  • 2 locations
Study on Impact of Edoxaban Treatment in Cancer Patients With Venous Thromboembolism During Antineoplastic Therapy

This is a multicentric, phase IV study. In this study patients that are receiving an antineoplastic treatment and that have been diagnosed with venous thromboembolism will receive edoxaban as

antineoplastic agents
primary cancer
carcinoma
non-melanoma skin cancer
heparin
  • 0 views
  • 24 Jan, 2021
  • 18 locations
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

The clinical significance of pulmonary embolism (PE) limited to the subsegmental pulmonary arteries, so called isolated subsegmental pulmonary embolism (SSPE), remains controversial. Whether isolated SSPE represents "true" PE, a clinically more benign form of PE, a physiologic lung clearing process, or a false positive result (artifact) is currently unclear and …

thrombosis
pulmonary embolism
drug test
deep vein thrombosis
anticoagulants
  • 40 views
  • 11 Feb, 2021
  • 31 locations
A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism

venous thromboembolism and upper gastrointestinal, hepatobiliary, or pancreatic cancer, based on a group sequential design. Enrolled patients will be randomized in a 1:1 ratio. Patients will be

cholangiocarcinoma
carcinoma
kidney function test
prothrombin
cancer chemotherapy
  • 13 views
  • 23 Jan, 2021
  • 1 location
Exercise Intolerance and Skeletal Muscle Bioenergetics in Children With Deep Venous Thrombosis

This is a prospective cohort study of 30 patients who are 8-21 years of age with venous thromboembolism (VTE)- either lower extremity deep venous thrombosis (DVT) or pulmonary embolism (PE).

thrombosis
deep venous thrombosis of lower extremity
venous thrombosis
embolism
deep vein thrombosis
  • 0 views
  • 25 Jan, 2021
  • 1 location